103 A Medulloblastoma brain slice culture radiotherapy platform to dually assess therapeutic efficacy and toxic

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Abstract Introduction Medulloblastoma is the most common malignant childhood brain tumour. Radiotherapy (RT) forms a key treatment pillar but is associated with significant late effects. Ex vivo brain slice cultures present a translational model that overcomes limitations of existing in vitro and in vivo alternatives. Slice cultures provide a native “scaffold”, with representative cellular architecture and extracellular matrix (ECM), upon which cancer cell growth and invasion can be tracked in real-time. We describe an organotypic brain slice culture (OSC) model for Group3 medulloblastoma (MBGrp3), amenable to long-term culture and irradiation. Method MBGrp3 spheroids (g-MYC-tdTomato) were cultured to an optimised diameter of 250-350µm in ultra-low-attachment plates. Murine cerebellar OSCs were prepared using a vibratome and cultured on transwell inserts. Co-cultures were established at 72-hours, and RT delivered 48 hours later using a Small-Animal-Radiation-Research-Platform (SARRP). 1, 3 or 5 daily fractions (1.8Gy) or a single cumulative dose (9Gy) was delivered. Tissue toxicity was assessed through live/dead staining and ToxiLight® assay. Growth and invasion was quantified in real-time (live multi-photon-microscopy) and spheroid volume/invasion analysed (Huygen’s). OSCs were fixed at endpoint for confocal microscopy to assess DNA damage (γH2AX) and cellular architecture. Results Control OSCs maintained viability long-term (21-days) with preserved cellular architecture and ECM. Live/dead staining revealed dose-dependent tissue toxicity following RT, with 5 fractions or a single cumulative dose significantly reducing viability (p < 0.05). DNA damage accumulated over time in culture and was dose-dependent. Our multi-photon pipeline provided repeat live volumetric quantification of spheroid growth. Conclusions Fractionated RT of OSCs is feasible, demonstrating dose-dependent DNA damage. This model serves as a basis for future studies to test radio-sensitising agents wherein cancer cell growth and invasion can be modelled in tandem with tissue toxicity.